THE CIGNA GROUP (CI) Stock Price & Overview
NYSE:CI • US1255231003
The current stock price of CI is 271.63 USD. Today CI is down by -3.43%. In the past month the price decreased by -4.53%. In the past year, price decreased by -15.39%.
CI Key Statistics
- Market Cap
- 71.564B
- P/E
- 9.10
- Fwd P/E
- 8.69
- EPS (TTM)
- 29.85
- Dividend Yield
- 2.16%
CI Stock Performance
CI Stock Chart
CI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CI. When comparing the yearly performance of all stocks, CI is a bad performer in the overall market: 74.74% of all stocks are doing better.
CI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CI. There are concerns on the financial health of CI while its profitability can be described as average.
CI Earnings
On February 5, 2026 CI reported an EPS of 8.08 and a revenue of 72.47B. The company missed EPS expectations (-0.41% surprise) and beat revenue expectations (0.76% surprise).
CI Forecast & Estimates
33 analysts have analysed CI and the average price target is 340.16 USD. This implies a price increase of 25.23% is expected in the next year compared to the current price of 271.63.
For the next year, analysts expect an EPS growth of 4.75% and a revenue growth 4.26% for CI
CI Groups
Sector & Classification
CI Financial Highlights
Over the last trailing twelve months CI reported a non-GAAP Earnings per Share(EPS) of 29.85. The EPS increased by 9.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.29% | ||
| ROA | 3.89% | ||
| ROE | 14.7% | ||
| Debt/Equity | 0.74 |
CI Ownership
CI Latest News, Press Relases and Analysis
CI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.74 | 99.131B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 99.07 | 26.592B | ||
| LH | LABCORP HOLDINGS INC | 14.97 | 22.356B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.55 | 21.887B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.75B | ||
| DVA | DAVITA INC | 10.66 | 10.071B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.92 | 8.03B | ||
| CHE | CHEMED CORP | 16.82 | 5.617B | ||
| RDNT | RADNET INC | 76.27 | 4.696B | ||
| OPCH | OPTION CARE HEALTH INC | 15.64 | 4.668B | ||
| HNGE | HINGE HEALTH INC-A | 23.9 | 3.632B | ||
| HIMS | HIMS & HERS HEALTH INC | 28.82 | 3.588B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CI
Company Profile
The Cigna Group is a global health company, which engages in the provision of global health services. The company is headquartered in Bloomfield, Connecticut. The firm has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
Company Info
THE CIGNA GROUP
900 Cottage Grove Road
Bloomfield CONNECTICUT 06002 US
CEO: David M. Cordani
Employees: 73500
Phone: 18602266000
THE CIGNA GROUP / CI FAQ
What does CI do?
The Cigna Group is a global health company, which engages in the provision of global health services. The company is headquartered in Bloomfield, Connecticut. The firm has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
What is the stock price of THE CIGNA GROUP today?
The current stock price of CI is 271.63 USD. The price decreased by -3.43% in the last trading session.
Does THE CIGNA GROUP pay dividends?
THE CIGNA GROUP (CI) has a dividend yield of 2.16%. The yearly dividend amount is currently 5.53.
What is the ChartMill technical and fundamental rating of CI stock?
CI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Which stock exchange lists CI stock?
CI stock is listed on the New York Stock Exchange exchange.
What is the analyst forecast for CI stock?
33 analysts have analysed CI and the average price target is 340.16 USD. This implies a price increase of 25.23% is expected in the next year compared to the current price of 271.63.
Is THE CIGNA GROUP (CI) expected to grow?
The Revenue of THE CIGNA GROUP (CI) is expected to grow by 4.26% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.